<DOC>
	<DOCNO>NCT00575939</DOCNO>
	<brief_summary>It well know HIV-infected subject frequently experience hyperlipidemia , insulin resistance , visceral adiposity , know increase risk atherosclerosis . Several cohort show increased risk heart disease people HIV . The effect HIV treatment versus HIV incidence heart disease unclear . In study investigator assess effect carotid IMT initiation antiretroviral combination know minimal effect lipid insulin resistance . We also assess change several inflammation cardiovascular marker , well endothelial activation marker , change relate therapy-induced change immunologic , virologic metabolic marker .</brief_summary>
	<brief_title>Antiretrovirals Rate Progression Carotid Artery Intima-medial Thickness HIV</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<criteria>Inclusion Criteria HIV positive group : HIV1 infection Age least 18 year Na√Øve antiretroviral therapy CD4 cell count &gt; 400 cells/mm3 For control : Age least 18 year , know HIV infection , know medical condition require chronic use prescription medication . Exclusion Criteria ( group ) : Diabetes Pregnant breastfeed Women child bear age refuse unable use appropriate method contraception entire study period . Active infectious inflammatory condition In jail involuntarily incarcerate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>HIV</keyword>
	<keyword>IMT</keyword>
	<keyword>coronary</keyword>
	<keyword>Treatment Naive</keyword>
</DOC>